Ergoteles’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Ergoteles’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-86,922	Closed	-$8.08M	–	1781
2021 Q4	$8.08M	Buy	+86,922	New	+$5.73M	0.31%	70

Ergoteles's ARNA Position: Q1 2022 in Review

Ergoteles sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 86,922 shares — an estimated $8.08M sold.

Ergoteles first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $8.08M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Ergoteles reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Ergoteles sold 86,922 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $8.08M.
Ergoteles first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Ergoteles's Arena Pharmaceuticals Inc position peaked at $8.08M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.